arrow
Back
F

Franck Rousseau

centre national de la recherche scientifique (cnrs)

45H-index
226Paper Count
1.0WCitation Count
Published Papers 52
Publication Date
Low power plasma spray assisted thermal barrier coating repair without the plugging of cooling holes
err2021-04-01
err3
errOAAI
errRousseau, F.; Guyon, C.; Morvan, D.; Bacos, M-P; Lavigne, O.; Rio, C.; Guinard, C.; Chevillard, B.
errShare
errSave
Performance of the Transport Layer Security Handshake Over 6TiSCH
errSENSORS
IF3.5
err2021-03-21
err4
errOAAI
errClaeys, Timothy; Vucinic, Malisa; Watteyne, Thomas; Rousseau, Franck; Tourancheau, Bernard
errShare
errSave
DINAS: A Lightweight and Efficient Distributed Naming Service for All-IP Wireless Sensor Networks
err2017-06-01
err10
PREAI
errAmoretti, Michele; Alphand, Olivier; Ferrari, Gianluigi; Rousseau, Franck; Duda, Andrzej
errShare
errSave
GreenNet: An Energy-Harvesting IP-Enabled Wireless Sensor Network
err2015-10-01
err34
PREAI
errVarga, Liviu-Octavian; Romaniello, Gabriele; Vucinic, Malisa; Favre, Michel; Banciu, Andrei; Guizzetti, Roberto; Planat, Christophe; Urard, Pascal; Heusse, Martin; Rousseau, Franck; Alphand, Olivier; Duble, Etienne; Duda, Andrzej
errShare
errSave
errShare
errSave
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
err2013-07-15
err68
PREAI
errMcCallum, R. W.; Lembo, A.; Esfandyari, T.; Bhandari, B. R.; Ejskjaer, N.; Cosentino, C.; Helton, N.; Mondou, E.; Quinn, J.; Rousseau, F.
errShare
errSave
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
err2012-12-23
err67
PREAI
errEjskjaer, N.; Wo, J. M.; Esfandyari, T.; Jamal, M. Mazen; Dimcevski, G.; Tarnow, L.; Malik, R. A.; Hellstrom, P. M.; Mondou, E.; Quinn, J.; Rousseau, F.; McCallum, R. W.
errShare
errSave
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
err2012-02-01
err139
errOAAI
errRatziu, Vlad; Sheikh, Muhammad Y.; Sanyal, Arun J.; Lim, Joseph K.; Conjeevaram, Hari; Chalasani, Naga; Abdelmalek, Manal; Bakken, Anezi; Renou, Christophe; Palmer, Melissa; Levine, Robert A.; Bhandari, B. Raj; Cornpropst, Melanie; Liang, Wei; King, Benjamin; Mondou, Elsa; Rousseau, Franck S.; McHutchison, John; Chojkier, Mario
errShare
errSave
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
err2011-01-01
err420
errOAAI
errHeathcote, E. Jenny; Marcellin, Patrick; Buti, Maria; Gane, Edward; De Man, Robert A.; Krastev, Zahary; Germanidis, George; Lee, Samuel S.; Flisiak, Robert; Kaita, Kelly; Manns, Michael; Kotzev, Iskren; Tchernev, Konstantin; Buggisch, Peter; Weilert, Frank; Kurdas, Oya Ovunc; Shiffman, Mitchell L.; Trinh, Huy; Gurel, Selim; Snow-Lampart, Andrea; Borroto-Esoda, Katyna; Mondou, Elsa; Anderson, Jane; Sorbel, Jeff; Rousseau, Franck
errShare
errSave
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
err2011-01-01
err269
PREAI
errLiaw, Yun-Fan; Sheen, I-Shyan; Lee, Chuan-Mo; Akarca, Ulus Salih; Papatheodoridis, George V.; Wong, Florence Suet-Hing; Chang, Ting-Tsung; Horban, Andrzej; Wang, Chia; Kwan, Peter; Buti, Maria; Prieto, Martin; Berg, Thomas; Kitrinos, Kathryn; Peschell, Ken; Mondou, Elsa; Frederick, David; Rousseau, Franck; Schiff, Eugene R.
errShare
errSave
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
err2010-10-01
err122
errOAAI
errBerg, Thomas; Marcellin, Patrick; Zoulim, Fabien; Moller, Bernd; Trinh, Huy; Chan, Sing; Suarez, Emilio; Lavocat, Fabien; Snow-Lampart, Andrea; Frederick, David; Sorbel, Jeff; Borroto-Esoda, Katyna; Oldach, David; Rousseau, Franck
errShare
errSave
SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION
err2010-04-01
err3
errOAAI
errManns, M. P.; Lawitz, E.; Hoepelman, A. I. M.; Choi, H. J.; Lee, J. Y.; Cornpropst, M.; Liang, W.; King, B.; Hirsch, K. R.; Oldach, D.; Rousseau, F. S.
errShare
errSave
HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT
err2010-04-01
err13
errOAAI
errGane, E.; Heathcote, E. J.; Marcellin, P.; Dusheiko, G.; Jacobson, I.; de Man, R.; Zeuzem, S.; Nikolaidis, P.; Sorbel, J.; Mondou, E.; Anderson, J.; Rousseau, F.
errShare
errSave
EMTRICITABINE TENOFOVIR DF COMBINATION plus /- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS
err2010-04-01
err15
errOAAI
errTeperman, L.; Spivey, J.; Poordad, F.; Schiano, T.; Bzowej, N.; Pungpapong, S.; Martin, P.; Coombs, D.; Hirsch, K. R.; Anderson, J.; Rousseau, F.
errShare
errSave
SAFETY, TOLERABILITY AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)
err2010-04-01
err5
PREAI
errRatziu, V.; Chojkier, M.; Sheikh, M. Y.; Sanyal, A. J.; Lim, J. K.; Conjeevaram, H.; Chalasani, N.; Abdelmalek, M.; Bakken, A.; Renou, C.; Palmer, M.; Levine, R.; Bhandari, R.; Cornpropst, M.; Liang, W.; King, B.; Mondou, E.; Rousseau, F. S.
errShare
errSave
DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256
err2010-04-01
err13
PREAI
errLawitz, E. J.; Marbury, T. C.; Vince, B. D.; Grunenberg, N.; Rodriguez-Torres, M.; De Micco, M. P.; Tarro, J. N.; Shelton, M. J.; West, S.; Zong, J.; Bae, A.; Wong, K.; Mo, H. -M.; Oldach, D.; Delaney, W.; Rousseau, F.
errShare
errSave
errShare
errSave